Detalhe da pesquisa
1.
Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials.
Haematologica
; 107(9): 2051-2063, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34788984
2.
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial.
Lancet Haematol
; 9(4): e276-e288, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35358442
3.
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study.
Leukemia
; 36(3): 625-636, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34657128
4.
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial.
Lancet Haematol
; 9(4): e262-e275, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35358441
5.
IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.
Blood Adv
; 5(17): 3322-3332, 2021 09 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34477813
6.
Results from UKALL60+, a phase 2 study in older patients with untreated acute lymphoblastic leukemia.
Hemasphere
; 8(6): e88, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38846719